HMGB3 and ovarian carcinoma: HMGB3 is also known to be associated with the Wnt/β-catenin signaling pathway in both hematopoietic stem cells [23] and in cancer cells, including in epithelial ovarian cancer [53], cervical cancer [54,55], and colorectal cancer [34,56,57].